Richard Kim, MD, Moffitt Cancer Center
Advertisement
Articles by Richard Kim, MD, Moffitt Cancer Center
Advertisement
Latest Updated Articles
Updates in Frontline Treatment of Metastatic Liver CancerPublished: July 24th 2020 | Updated:
Initiation of Systemic Therapy for mHCCPublished: July 24th 2020 | Updated:
Overview and Diagnosis of HCCPublished: July 24th 2020 | Updated:
mHCC: Influence of PD-L1 Inhibitors on Second-Line TherapyPublished: July 24th 2020 | Updated:
ASCO 2020 Data for Treatment of Advanced HCCPublished: July 24th 2020 | Updated:
Role of VEGF TKIs for Treatment of HCCPublished: July 24th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5